Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5-HT2C receptor is a subtype of the serotonin receptor family, acting as a G protein-coupled receptor primarily coupled to Gq/11 proteins. It is highly expressed in the central nervous system and plays critical roles in regulating food intake, anxiety, and other functions. Polymorphisms in the HTR2C gene are associated with psychiatric disorders, substance use disorders, obesity, and other conditions, making it a target for antipsychotics, appetite suppressants, and other potential therapeutic agents.
Agonism or antagonism of the 5-HT2C receptor, leading to downstream effects via Gq/11 signaling (PLCβ activation, IP₃/DAG production, Ca²⁺/PKC activation) and potentially Gq/13 signaling (PLA₂ activation, arachidonic acid release, cGMP production).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor Subtype 5-HT2C.